Elutia sells BioEnvelope business to Boston Scientific for $88 million

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. SPCX
2. SBUX
3. LEVI
4. NVDA
5. GOOGL
6. AAPL
7. SPY
8. APLD
9. ORCL
10. USO

Go back to Elutia sells BioEnvelope business to Boston Scientific for $88 million

Elutia Announces Sale of BioEnvelope Business to Boston Scientific Corporation for $88 Million

September 9, 2025 8:30 AM EDT

- Transaction affirms the strength of Elutias proprietary drug-eluting biologics platform and fully funds advancement of NXT-41 in breast reconstruction -

- Company to provide update at the H.C. Wainwright 27th Annual Global Investment Conference on Wednesday, September 10 at 9:30 a.m. ET -

GAITHERSBURG, Md., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (Elutia or the Company), a pioneer in drug-eluting biomatrix technologies, today announced it has entered into a definitive agreement to sell its EluPro and CanGaroo® bioenvelopes, designed to protect patients receiving implantable... More